[1]Kaur P,Porras TB,Ring A,et al.Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer[J].Sci Rep,2019,9(1):1482.
[2]Liu J,Lichtenberg T,Hoadley KA,et al.An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics[J].Cell,2018,173(2):400-416.
[3]Chiu HS,Somvanshi S,Patel E,et al.Pan-cancer analysis of incRNA regulation supports their targeting of cancer genes in each tumor context[J].Cell Rep,2018,23(1):297-312.
[4]de Almeida BP,Vieira AF,Paredes J,et al.Pan-cancer association of a centrosome amplification gene expression signature with genomic alterations and clinical outcome[J].PLoS Comput Biol,2019,15(3):e1006832.
[5] Cline MS,Craft B,Swatloski T,et al.Exploring TCGA pan-cancer data at the UCSC cancer genomics browser[J].Sci Rep,2013,3(2652):1-6.
[6]Wang K,Zhang DL,Long B,et al.NFAT4-dependent miR-324-5p regulates mitoch- ondrial morphology and cardiomyocyte cell death by targeting MTFR1[J].Cell Death Dis,2015,6(e2007):1-9.
[7]Chandrashekar DS,Bashel B,Balasubramanya SAH,et al.UALCAN:A portal for facilitating tumor subgroup gene expression and survival analyses[J].Neoplasia,2017,19(8):649-658.
[8]Szklarczyk D,Franceschini A,Wyder S,et al.STRING v10:Protein-protein interaction networks,integrated over the tree of life[J].Nucleic Acids Res,2015,43(Database issue):D447-D452.
[9] Huang da W,Sherman BT,Lempicki RA.Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources [J].Nature Protocols,2009,4(1):D447-D452.
[10]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2018,68(6):394-424.
[11]Marusyk A,Polyak K.Tumor heterogeneity:Causes and consequences[J].Biochim Biophys Acta,2010,1805(1):105-117.
[12]Collins FS,Varmus H.A new initiative on precision medicine[J].N Engl J Med,2015,372(9):793-795.
[13] Rubio-Perez C,Tamborero D,Schroeder MP,et al.In silico prescription of anticancer drugsto cohorts of 28 tumor types reveals targeting opportunities[J].Cancer Cell,2015,27(3):382-396.
[14]Tonachini L,Monticone M,Puri C,et al.Chondrocyte protein with a poly-proline region (CHPPR) is a novel mitochondrial protein and promotes mitochondrial fission[J].J Cell Physiol,2004,201(3):470-482.
[15]Monticone M,Tonachini L,Tavella S,et al.Impaired expression of genes coding for reactive oxygen species scavenging enzymes in testes of MTFR1/CHPPR-deficient mice[J].Reproduction,2007,134(3):483-492.
[16] Guido C,Whitaker-Menezes D,Lin Z,et al.Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts,driving stromal lactate production,and early tumor growth[J].Oncotarget,2012,3(8):798-810.